Drug Information

Drug General Information
Drug ID
D0D0OD
Former ID
DNC012101
Drug Name
N-(3,3-Dimethyl-butyl)-4-indol-1-yl-benzamide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [526184]
Formula
C21H24N2O
Canonical SMILES
CC(C)(C)CCNC(=O)C1=CC=C(C=C1)N2C=CC3=CC=CC=C32
InChI
1S/C21H24N2O/c1-21(2,3)13-14-22-20(24)17-8-10-18(11-9-17)23-15-12-16-6-4-5-7-19(16)23/h4-12,15H,13-14H2,1-3H3,(H,22,24)
InChIKey
WFFDNQLEAMWQBV-UHFFFAOYSA-N
PubChem Compound ID
11023651
Target and Pathway
Target(s) Potassium voltage-gated channel subfamily KQT member 1 Target Info Inhibitor [526184]
KEGG Pathway Adrenergic signaling in cardiomyocytes
Cholinergic synapse
Gastric acid secretion
Pancreatic secretion
Protein digestion and absorption
Vibrio cholerae infection
PathWhiz Pathway Muscle/Heart Contraction
Reactome Voltage gated Potassium channels
WikiPathways SIDS Susceptibility Pathways
Potassium Channels
miR-targeted genes in muscle cell - TarBase
miR-targeted genes in lymphocytes - TarBase
TarBasePathway
References
Ref 526184J Med Chem. 2001 Nov 8;44(23):3764-7.Design and synthesis of 4-substituted benzamides as potent, selective, and orally bioavailable I(Ks) blockers.
Ref 526184J Med Chem. 2001 Nov 8;44(23):3764-7.Design and synthesis of 4-substituted benzamides as potent, selective, and orally bioavailable I(Ks) blockers.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.